Lisanne Lutter

Lisanne Lutter

Auto-generated profile, based on publicly available information

Lisanne Lutter

Center for Translational Immunology, University Medical Centre Utrecht, Utrecht, Netherlands

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
GMGerdien Mijnheer
Gerdien Mijnheer
LLLisanne Lutter
Lisanne Lutter
MMMichal Mokry
Michal Mokry
MWMarlot van der Wal
Marlot van der Wal
RSRianne Scholman
Rianne Scholman
FWF. Van Wijk
F. Van Wijk
Treg cells are critical regulators of immune homeostasis, and environment-driven Treg cell differentiation into effector (e)Treg cells is crucial for optimal functioning. However, human Treg cell programming in inflammation is unclear. Here, we combine transcriptional and epigenetic profiling to identify a human eTreg cell signature. Inflammation-derived functional Treg cells have a transcriptional profile characterized by upregulation of both a core Treg cell (FOXP3, CTLA4, TIGIT) and effector program (GITR, BLIMP-1, BATF). We identify a specific human eTreg cell signature that includes the vitamin D receptor (VDR) as a predicted regulator in eTreg cell differentiation. H3K27ac/H3K4me1 occupancy indicates an altered (super-)enhancer landscape, including enrichment of the VDR and BATF binding motifs. The Treg cell profile has striking overlap with tumor-infiltrating Treg cells. Our data demonstrate that human inflammation-derived Treg cells acquire a conserved and specific eTreg cell profile guided by epigenetic changes, and fine-tuned by environment-specific adaptations.

4 July 2018 in Nature Reviews Gastroenterology & Hepatology
Verified
Journal Article
Closed access
PDF file
LLLisanne Lutter
Lisanne Lutter
DKDavid P. Hoytema van Konijnenburg
David P. Hoytema van Konijnenburg
EBEelco C. Brand
Eelco C. Brand
BOBas Oldenburg
Bas Oldenburg
FWF. Van Wijk
F. Van Wijk

30 September 2022 in Clinical & Translational Immunology
Verified
Journal Article
Open access
LLLisanne Lutter
Lisanne Lutter
MWM Marlot van der Wal
M Marlot van der Wal
EBEelco C Brand
Eelco C Brand
PMPatrick Maschmeyer
Patrick Maschmeyer
SVSebastiaan Vastert
Sebastiaan Vastert
FWF. Van Wijk
F. Van Wijk
Objective: Tregs are crucial for immune regulation, and environment‐driven adaptation of effector (e)Tregs is essential for local functioning. However, the extent of human Treg heterogeneity in inflammatory settings is unclear.Methods: We combined single‐cell RNA‐ and TCR‐sequencing on Tregs derived from three to six patients with juvenile idiopathic arthritis (JIA) to investigate the functional heterogeneity of human synovial fluid (SF)‐derived Tregs from inflamed joints. Confirmation and suppressive function of the identified Treg clusters was assessed by flow cytometry.Results: Four Treg clusters were identified; incoming, activated eTregs with either a dominant suppressive or cytotoxic profile, and GPR56+CD161+CXCL13+ Tregs. Pseudotime analysis showed differentiation towards either classical eTreg profiles or GPR56+CD161+CXCL13+ Tregs supported by TCR data. Despite its most differentiated phenotype, GPR56+CD161+CXCL13+ Tregs were shown to be suppressive. Furthermore, BATF was identified as an overarching eTreg regulator, with the novel Treg‐associated regulon BHLHE40 driving differentiation towards GPR56+CD161+CXCL13+ Tregs, and JAZF1 towards classical eTregs.Conclusion: Our study reveals a heterogeneous population of Tregs at the site of inflammation in JIA. SF Treg differentiate to a classical eTreg profile with a more dominant suppressive or cytotoxic profile that share a similar TCR repertoire, or towards GPR56+CD161+CXCL13+ Tregs with a more distinct TCR repertoire. Genes characterising GPR56+CD161+CXCL13+ Tregs were also mirrored in other T‐cell subsets in both the tumor and the autoimmune setting. Finally, the identified key regulators driving SF Treg adaptation may be interesting targets for autoimmunity or tumor interventions.

1 January 2021 in Cellular and Molecular Gastroenterology and Hepatology
Verified
Journal Article
Open access
LLLisanne Lutter
Lisanne Lutter
BRBritt Roosenboom
Britt Roosenboom
EBEelco C. Brand
Eelco C. Brand
JLJosé J. ter Linde
José J. ter Linde
BOBas Oldenburg
Bas Oldenburg
FWF. Van Wijk
F. Van Wijk
Tissue-resident memory T cells (Trm), both of the CD4 and CD8 lineage, have been implicated in disease flares in inflammatory bowel disease. However, data is conflicting regarding the profile of human CD8+ Trm, with studies suggesting both pro-inflammatory and regulatory functions. It is crucial to understand the functional profile of these cells in the context of (new) therapeutic strategies targeting (trafficking of) gut Trm cells. Here, we performed imaging mass cytometry, flow cytometry and RNA-sequencing to compare lamina propria and intraepithelial CD103+/-CD69+CD8+ T cells in healthy controls and patients with active ileal Crohn's disease. Our data revealed that lamina propria CD103+CD69+CD8+ T cells have a classical Trm profile with active pathways for regulating cell survival/death and cytokine signaling, whereas intraepithelial CD103+CD69+CD8+ T cells display tightly regulated innate-like cytotoxic profile. Furthermore, within lamina propria CD8+CD103- Trm an Itgb2+GzmK+KLRG1+ population distinct from CD103+ CD8+ Trm is found. During chronic inflammation, especially intraepithelial CD103+CD69+CD8+ T cells displayed an innate pro-inflammatory profile with concurrent loss of homeostatic functions. Altogether, these compartmental and inflammation-induced differences indicate that therapeutic strategies could have a different impact on the same immune cells depending on the local compartment and presence of an inflammatory milieu, and should be taken into account when investigating short- and long-term effects of new gut T cell targeting drugs.

3 September 2024 in JCI Insight
Verified
Journal Article
Open access
PDF file
ESElise S. Saager
Elise S. Saager
ASArthur H. van Stigt
Arthur H. van Stigt
BLButstabong Lerkvaleekul
Butstabong Lerkvaleekul
LLLisanne Lutter
Lisanne Lutter
AHAnneke H. Hellinga
Anneke H. Hellinga
FWF. Van Wijk
F. Van Wijk
Breastfeeding provides important immunological benefits to the neonate, but how the different immunoactive components in breastmilk contribute to immunity remains poorly understood. Here, we characterized human breastmilk T cells using single-cell RNA-Seq and flow cytometry. Breastmilk contained predominantly memory T cells, with expression of immune signaling genes, high proliferation, and an effector Th1/cytotoxic profile with high cytokine production capacities. Elevated activation was balanced by an enriched Treg population and immune regulatory markers in conventional memory T cells. Gene and surface expression of tissue-residency markers indicate that breastmilk T cells represented tissue-adapted rather than circulatory T cells. In addition, breastmilk T cells had a broad homing profile and higher activation markers in these migratory subsets. The partly overlapping transcriptome profile between breastmilk and breast tissue T cells, particularly cytotoxic T cells, might support a role in local immune defense in the mammary gland. However, unique features of breastmilk, such as Tregs, might imply an additional role in neonatal immune support. We found some correlations between the breastmilk T cell profile and clinical parameters, most notably with maternal and household factors. Together, our data suggest that breastmilk contains an adapted T cell population that exerts their function in specific tissue sites.

11 August 2023 in Clinical and Experimental Immunology
Verified
Journal Article
Open access
PDF file
LLLisanne Lutter
Lisanne Lutter
JLJosé J M ter Linde
José J M ter Linde
EBEelco C Brand
Eelco C Brand
DKDavid P Hoytema van Konijnenburg
David P Hoytema van Konijnenburg
BRBritt Roosenboom
Britt Roosenboom
FWF. Van Wijk
F. Van Wijk
The mucosal immune system is implicated in the etiology and progression of inflammatory bowel diseases. The lamina propria and epithelium of the gut mucosa constitute two separate compartments, containing distinct T-cell populations. Human CD4 T-cell programming and regulation of lamina propria and epithelium CD4 T cells, especially during inflammation, remain incompletely understood. We performed flow cytometry, bulk, and single-cell RNA-sequencing to profile ileal lamina propria and intraepithelial CD4 T cells (CD4CD8αα, regulatory T cells (Tregs), CD69− and CD69high Trm T cells) in controls and Crohn’s disease (CD) patients (paired non-inflamed and inflamed). Inflammation results in alterations of the CD4 T-cell population with a pronounced increase in Tregs and migrating/infiltrating cells. On a transcriptional level, inflammation within the epithelium induced T-cell activation, increased IFNγ responses, and an effector Treg profile. Conversely, few transcriptional changes within the lamina propria were observed. Key regulators including the chromatin remodelers ARID4B and SATB1 were found to drive compartment-specific transcriptional programming of CD4 T(reg) cells. In summary, inflammation in CD patients primarily induces changes within the epithelium and not the lamina propria. Additionally, there is compartment-specific CD4 T-cell imprinting, driven by shared regulators, between the lamina propria and the epithelium. The main consequence of intraepithelial adaptation, irrespective of inflammation, seems to be an overall dampening of broad (pro-inflammatory) responses and tight regulation of lifespan. These data suggest differential regulation of the lamina propria and epithelium, with a specific regulatory role in the inflamed epithelium.